Cargando…
Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp
INTRODUCTION: Increased postprandial glucose (PPG) is associated with high glycated haemoglobin levels and is an independent risk factor for cardiovascular diseases. The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naïv...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873325/ https://www.ncbi.nlm.nih.gov/pubmed/35044568 http://dx.doi.org/10.1007/s13300-021-01196-7 |
_version_ | 1784657439601197056 |
---|---|
author | Yang, Wenying Akhtar, Shahid Franek, Edward Haluzík, Martin Hirose, Takahisa Kalyanam, Balamurali Kar, Soumitra Wu, Ted Gogas Yavuz, Dilek Unnikrishnan, Ambika Gopalakrishnan |
author_facet | Yang, Wenying Akhtar, Shahid Franek, Edward Haluzík, Martin Hirose, Takahisa Kalyanam, Balamurali Kar, Soumitra Wu, Ted Gogas Yavuz, Dilek Unnikrishnan, Ambika Gopalakrishnan |
author_sort | Yang, Wenying |
collection | PubMed |
description | INTRODUCTION: Increased postprandial glucose (PPG) is associated with high glycated haemoglobin levels and is an independent risk factor for cardiovascular diseases. The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naïve or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials. METHODS: This was a post hoc analysis of data from 13 phase 3, randomised, parallel-group, open-label IDegAsp trials in patients with T2D. The pooled baseline clinical data were analysed for insulin-naïve and insulin-experienced groups; and each group was split into subgroups of Asian and non-Asian patients, respectively, and analysed accordingly. Baseline self-monitored blood glucose (SMBG) values at breakfast, lunch and the evening meal (before and 90 min after each meal) were used to assess PPG increments. The estimated differences in baseline SMBG increment between the Asian and non-Asian subgroups were analysed. RESULTS: Clinical data from 4750 participants (insulin-naïve, n = 1495; insulin-experienced, n = 3255) were evaluated. In the insulin-naïve group, the postprandial SMBG increment was significantly greater in the Asian versus the non-Asian subgroup at breakfast (estimated difference 28.67 mg/dL, 95% confidence interval [CI] 18.35, 38.99; p < 0.0001), lunch (17.34 mg/dL, 95% CI 6.47, 28.21; p = 0.0018) and the evening meal (16.19 mg/dL, 95% CI 5.04, 27.34; p = 0.0045). In the insulin-experienced group, the postprandial SMBG increment was significantly greater in the Asian versus non-Asian subgroup at breakfast (estimated difference 13.81 mg/dL, 95% CI 9.19, 18.44; p < 0.0001) and lunch (29.18 mg/dL, 95% CI 24.22, 34.14; p < 0.0001), but not significantly different at the evening meal. CONCLUSION: In this post hoc analysis, baseline PPG increments were significantly greater in Asian participants with T2D than in their non-Asian counterparts at all mealtimes, with the exception of the evening meal in insulin-experienced participants. Asian adults with T2D may benefit from the use of regimens that control PPG excursions. CLINICAL TRIAL NUMBERS: NCT02762578, NCT01814137, NCT01513590, NCT01009580, NCT01713530, NCT02648217, NCT01045447, NCT01365507, NCT01045707, NCT01272193, NCT01059812, NCT01680341, NCT02906917. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-021-01196-7. |
format | Online Article Text |
id | pubmed-8873325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-88733252022-03-02 Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp Yang, Wenying Akhtar, Shahid Franek, Edward Haluzík, Martin Hirose, Takahisa Kalyanam, Balamurali Kar, Soumitra Wu, Ted Gogas Yavuz, Dilek Unnikrishnan, Ambika Gopalakrishnan Diabetes Ther Original Research INTRODUCTION: Increased postprandial glucose (PPG) is associated with high glycated haemoglobin levels and is an independent risk factor for cardiovascular diseases. The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naïve or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials. METHODS: This was a post hoc analysis of data from 13 phase 3, randomised, parallel-group, open-label IDegAsp trials in patients with T2D. The pooled baseline clinical data were analysed for insulin-naïve and insulin-experienced groups; and each group was split into subgroups of Asian and non-Asian patients, respectively, and analysed accordingly. Baseline self-monitored blood glucose (SMBG) values at breakfast, lunch and the evening meal (before and 90 min after each meal) were used to assess PPG increments. The estimated differences in baseline SMBG increment between the Asian and non-Asian subgroups were analysed. RESULTS: Clinical data from 4750 participants (insulin-naïve, n = 1495; insulin-experienced, n = 3255) were evaluated. In the insulin-naïve group, the postprandial SMBG increment was significantly greater in the Asian versus the non-Asian subgroup at breakfast (estimated difference 28.67 mg/dL, 95% confidence interval [CI] 18.35, 38.99; p < 0.0001), lunch (17.34 mg/dL, 95% CI 6.47, 28.21; p = 0.0018) and the evening meal (16.19 mg/dL, 95% CI 5.04, 27.34; p = 0.0045). In the insulin-experienced group, the postprandial SMBG increment was significantly greater in the Asian versus non-Asian subgroup at breakfast (estimated difference 13.81 mg/dL, 95% CI 9.19, 18.44; p < 0.0001) and lunch (29.18 mg/dL, 95% CI 24.22, 34.14; p < 0.0001), but not significantly different at the evening meal. CONCLUSION: In this post hoc analysis, baseline PPG increments were significantly greater in Asian participants with T2D than in their non-Asian counterparts at all mealtimes, with the exception of the evening meal in insulin-experienced participants. Asian adults with T2D may benefit from the use of regimens that control PPG excursions. CLINICAL TRIAL NUMBERS: NCT02762578, NCT01814137, NCT01513590, NCT01009580, NCT01713530, NCT02648217, NCT01045447, NCT01365507, NCT01045707, NCT01272193, NCT01059812, NCT01680341, NCT02906917. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13300-021-01196-7. Springer Healthcare 2022-01-19 2022-02 /pmc/articles/PMC8873325/ /pubmed/35044568 http://dx.doi.org/10.1007/s13300-021-01196-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Yang, Wenying Akhtar, Shahid Franek, Edward Haluzík, Martin Hirose, Takahisa Kalyanam, Balamurali Kar, Soumitra Wu, Ted Gogas Yavuz, Dilek Unnikrishnan, Ambika Gopalakrishnan Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp |
title | Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp |
title_full | Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp |
title_fullStr | Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp |
title_full_unstemmed | Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp |
title_short | Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp |
title_sort | postprandial glucose excursions in asian versus non-asian patients with type 2 diabetes: a post hoc analysis of baseline data from phase 3 randomised controlled trials of idegasp |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873325/ https://www.ncbi.nlm.nih.gov/pubmed/35044568 http://dx.doi.org/10.1007/s13300-021-01196-7 |
work_keys_str_mv | AT yangwenying postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT akhtarshahid postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT franekedward postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT haluzikmartin postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT hirosetakahisa postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT kalyanambalamurali postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT karsoumitra postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT wuted postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT gogasyavuzdilek postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp AT unnikrishnanambikagopalakrishnan postprandialglucoseexcursionsinasianversusnonasianpatientswithtype2diabetesaposthocanalysisofbaselinedatafromphase3randomisedcontrolledtrialsofidegasp |